Diploma (DPLM) Receives “Add” Rating from Peel Hunt

Peel Hunt reiterated their add rating on shares of Diploma (LON:DPLM) in a research report sent to investors on Wednesday, March 27th, ThisIsMoney.Co.Uk reports.

A number of other research analysts have also weighed in on the company. HSBC initiated coverage on Diploma in a report on Tuesday, February 12th. They set a hold rating and a GBX 1,325 ($17.31) price objective for the company. Berenberg Bank lowered their price target on Diploma from GBX 1,435 ($18.75) to GBX 1,350 ($17.64) and set a hold rating for the company in a report on Tuesday, January 29th. Six analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of GBX 1,365.71 ($17.85).

Shares of Diploma stock traded up GBX 5 ($0.07) during trading hours on Wednesday, reaching GBX 1,590 ($20.78). 52,862 shares of the company’s stock were exchanged, compared to its average volume of 128,194. Diploma has a 52-week low of GBX 1,144 ($14.95) and a 52-week high of GBX 1,594 ($20.83). The firm has a market cap of $1.80 billion and a PE ratio of 33.40.

In related news, insider Johnny Thomson purchased 22,000 shares of Diploma stock in a transaction dated Monday, February 25th. The shares were acquired at an average price of GBX 1,349 ($17.63) per share, with a total value of £296,780 ($387,795.64). Also, insider Nigel Lingwood sold 115,723 shares of the stock in a transaction dated Tuesday, January 29th. The stock was sold at an average price of GBX 1,261 ($16.48), for a total transaction of £1,459,267.03 ($1,906,790.84).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery and minimally invasive surgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Featured Article: Understanding Stock Ratings

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.